Oscar Health, Inc. (NYSE:OSCR – Get Free Report) shares gapped down prior to trading on Tuesday . The stock had previously closed at $15.53, but opened at $14.94. Oscar Health shares last traded at $13.50, with a volume of 1,635,366 shares traded.
Wall Street Analyst Weigh In
Separately, Jefferies Financial Group started coverage on shares of Oscar Health in a research note on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price objective for the company. Two analysts have rated the stock with a sell rating, two have given a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $21.56.
Read Our Latest Report on OSCR
Oscar Health Stock Performance
Oscar Health (NYSE:OSCR – Get Free Report) last announced its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. On average, analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the company. JPMorgan Chase & Co. lifted its holdings in shares of Oscar Health by 348.7% in the 4th quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company’s stock worth $139,246,000 after buying an additional 8,051,379 shares during the period. BIT Capital GmbH raised its holdings in shares of Oscar Health by 5,711.6% in the fourth quarter. BIT Capital GmbH now owns 4,473,853 shares of the company’s stock valued at $60,129,000 after acquiring an additional 4,396,872 shares in the last quarter. Deerfield Management Company L.P. Series C lifted its stake in Oscar Health by 50.7% in the fourth quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company’s stock worth $159,062,000 after acquiring an additional 3,983,325 shares during the period. Hennessy Advisors Inc. grew its holdings in Oscar Health by 550.3% during the 4th quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company’s stock worth $56,292,000 after acquiring an additional 3,544,300 shares in the last quarter. Finally, Gilder Gagnon Howe & Co. LLC increased its position in Oscar Health by 51.4% during the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company’s stock valued at $85,154,000 after purchasing an additional 2,151,256 shares during the period. Institutional investors own 75.70% of the company’s stock.
About Oscar Health
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Read More
- Five stocks we like better than Oscar Health
- How to Calculate Return on Investment (ROI)
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- What Does Downgrade Mean in Investing?
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
- What Are Earnings Reports?
- Joby Aviation: From Prototype to Profitability
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.